Cited by 381Advanced Glycation End Products researchAldose Reductase and TaurineChronic Kidney Disease and Diabetes

The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.

The RAGE Axis: A Fundamental Mechanism Signaling Danger to the Vulnerable Vasculature

Open access

Yan, Shi Fang, Ramasamy, Ravichandran, Schmidt, Ann Marie·2010·Circulation Research

DOI 10.1161/circresaha.109.212217PMC PMC2862596

Open this paper in CoChat — free account Open PDF

Abstract

The immunoglobulin superfamily molecule RAGE (receptor for advanced glycation end product) transduces the effects of multiple ligands, including AGEs (advanced glycation end products), advanced oxidation protein products, S100/calgranulins, high-mobility group box-1, amyloid-beta peptide, and beta-sheet fibrils. In diabetes, hyperglycemia likely stimulates the initial burst of production of ligands that interact with RAGE and activate signaling mechanisms. Consequently, increased generation of proinflammatory and prothrombotic molecules and reactive oxygen species trigger further cycles of oxidative stress via RAGE, thus setting the stage for augmented damage to diabetic tissues in the face of further insults. Many of the ligand families of RAGE have been identified in atherosclerotic plaques and in the infarcted heart. Together with increased expression of RAGE in diabetic settings, we propose that release and accumulation of RAGE ligands contribute to exaggerated cellular damage. Stopping the vicious cycle of AGE-RAGE and RAGE axis signaling in the vulnerable heart and great vessels may be essential in controlling and preventing the consequences of diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circresaha.109.212217

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864
Self-citation
Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures
Tepper, O. M., Galiano, R. D., Capla, J. M., Kalka, C., Gagne, P. J., Jacobowitz, G. R., Levine, J. P., & Gurtner, G. C. (2002) · Circulation · doi:10.1161/01.cir.0000039526.42991.93 · Cited by 1,447
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Self-citation
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Self-citation
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D. M., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,103
Self-citation
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
Wautier, M., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e685 · Cited by 1,088
Self-citation
N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression
Kislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Yan, S. D., Hofmann, M. A., Yan, S. F., Pischetsrieder, M., Stern, D. M., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31740 · Cited by 868
Self-citation
Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.
Schmidt, A. M., Vianna, M., Gerlach, M. L., Brett, J., Ryan, J., Kao, J. J., Esposito, C., Hegarty, H. M., Hurley, W. L., & Clauss, M. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42137-0 · Cited by 833
Self-citation
S100B's double life: Intracellular regulator and extracellular signal
Donato, R., Sorci, G., Riuzzi, F., Arcuri, C., Bianchi, R., Brozzi, F., Tubaro, C., & Giambanco, I. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.009 · Cited by 747
Circulating Endothelial Progenitor Cells Are Reduced in Peripheral Vascular Complications of Type 2 Diabetes Mellitus
Fadini, G. P., Miorin, M., Facco, M., Bonamico, S., Baesso, I., Grego, F., Menegolo, M., de Kreutzenberg, S. V., Tiengo, A., Agostini, C., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.067 · Cited by 725
High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart
Andrassy, M., Volz, H. C., Igwe, J. C., Funke, B., Eichberger, S. N., Kaya, Z., Buss, S. J., Autschbach, F., Pleger, S. T., Lukić, I. K., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.769331 · Cited by 635
RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice
Bucciarelli, L. G., Wendt, T., Qu, W., Lu, Y., Lalla, E., Rong, L., Goova, M. T., Moser, B., Kislinger, T., Lee, D. C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000039325.03698.36 · Cited by 562
Self-citation
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane‐bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Raucci, A., Cugusi, S., Antonelli, A., Barabino, S. M. L., Monti, L. D., Bierhaus, A., Reiß, K., Säftig, P., & Bianchi, M. E. (2008) · The FASEB Journal · doi:10.1096/fj.08-109033 · Cited by 560
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
Liliensiek, B., Weigand, M. A., Bierhaus, A., Nicklas, W., Kasper, M. E., Hofer, S., Plachky, J., Gröne, H.-J., Kurschus, F. C., Schmidt, A. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18704 · Cited by 530
Self-citation
Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products
Dumitriu, I. E., Baruah, P., Valentinis, B., Voll, R. E., Herrmann, M., Nawroth, P. P., Arnold, B., Bianchi, M. E., Manfredi, A. A., & Rovere-Querini, P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7506 · Cited by 503
Morphologic Findings of Coronary Atherosclerotic Plaques in Diabetics
BURKE, A. P., Kolodgie, F. D., Zieske, A. W., Fowler, D. R., Weber, D. K., Varghese, P. J., Farb, A. A., & Virmani, R. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000131783.74034.97 · Cited by 490
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
Skyler, J. S., Bergenstal, R. M., Bonow, R. O., Buse, J. B., DEEDWANIA, P. C., Gale, E. A., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P. D., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.008 · Cited by 473
Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation
Palumbo, R., Sampaolesi, M., Marchis, F. D., Tonlorenzi, R., Colombetti, S., Mondino, A., Cossu, G., & Bianchi, M. E. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200304135 · Cited by 469
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
Liliensiek, B., Weigand, M. A., Bierhaus, A., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200418704 · Cited by 468
The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage
Muhammad, S., Barakat, W., Stoyanov, S., Murikinati, S. R., Yang, H., Tracey, K. J., Bendszus, M., Rossetti, G., Nawroth, P. P., Bierhaus, A., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2435-08.2008 · Cited by 416
Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
Soro-Paavonen, A., Watson, A. M. D., Li, J., Paavonen, K., Koitka, A., Calkin, A. C., Barit, D., Coughlan, M. T., Drew, B. G., Lancaster, G. I., et al. (2008) · Diabetes · doi:10.2337/db07-1808 · Cited by 407
Rage and arthritis: The G82S polymorphism amplifies the inflammatory response
Hofmann, M. A., Drury, S., Hudson, B. I., Gleason, M. R., Qu, W., Lu, Y., Lalla, E., Chitnis, S., Monteiro, J., Stickland, M. H., et al. (2002) · Genes & Immunity · doi:10.1038/sj.gene.6363861 · Cited by 383
Self-citation
The Receptor RAGE as a Progression Factor Amplifying Arachidonate-Dependent Inflammatory and Proteolytic Response in Human Atherosclerotic Plaques
Cipollone, F., Iezzi, A., Fazia, M. L., Zucchelli, M., Pini, B., Cuccurullo, C., Cesare, D. D., Blasis, G. D., Muraro, R., Bei, R., et al. (2003) · Circulation · doi:10.1161/01.cir.0000086014.80477.0d · Cited by 377
Self-citation
Identification, classification, and expression of RAGE gene splice variants
Hudson, B. I., Carter, A. M., Harja, E., Kalea, A. Z., Arriero, M., Yang, H., Grant, P. J., & Schmidt, A. M. (2007) · The FASEB Journal · doi:10.1096/fj.07-9909com · Cited by 366
Self-citation
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice
Harja, E., Bu, D.-X., Hudson, B. I., Chang, J. S., Shen, X., Hallam, K. M., Kalea, A. Z., Lu, Y., Rosario, R., Oruganti, S., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32703 · Cited by 365
Self-citation
Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
Hudson, B. I., Kalea, A. Z., Arriero, M. D. M., Harja, E., Boulanger, É., D’Agati, V. D., & Schmidt, A. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801465200 · Cited by 361
Self-citation
Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
Calcutt, N. A., Cooper, M. E., Kern, T. S., & Schmidt, A. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2476 · Cited by 356
Self-citation
The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation
Anderson, M. M., Requena, J. R., Crowley, J. R., Thorpe, S. R., & Heinecke, J. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3042 · Cited by 349
Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis
Forbes, J. M., Yee, L. T. L., Thallas, V., Lassila, M., Candido, R., Jandeleit-Dahm, K. A. M., Thomas, M. C., Burns, W. C., Deemer, E. K., Thorpe, S. R., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1813 · Cited by 314
Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.
Schmidt, A. M., Yan, S. D., Brett, J., Mora, R., Nowygrod, R., & Stern, D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116442 · Cited by 298
Self-citation
Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases
Zhang, L., Bukulin, M., Kojro, E., Roth, A., Metz, V. V., Fahrenholz, F., Nawroth, P. P., Bierhaus, A., & Postina, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806948200 · Cited by 294
S100A8 and S100A9 Mediate Endotoxin-Induced Cardiomyocyte Dysfunction via the Receptor for Advanced Glycation End Products
Boyd, J. H., Kan, B., Roberts, H., Wang, Y., & Walley, K. R. (2008) · Circulation Research · doi:10.1161/circresaha.107.167544 · Cited by 292
Exogenous High-Mobility Group Box 1 Protein Induces Myocardial Regeneration After Infarction via Enhanced Cardiac C-Kit + Cell Proliferation and Differentiation
Limana, F., Germani, A., Zacheo, A., Kajstura, J., Carlo, A. D., Borsellino, G., Leoni, O., Palumbo, R., Battistini, L., Rastaldo, R., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000186276.06104.04 · Cited by 289
RAGE: therapeutic target and biomarker of the inflammatory response—the evidence mounts
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0409230 · Cited by 283
Self-citation
ROLE OF TOLL-LIKE RECEPTORS 2 AND 4, AND THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS IN HIGH-MOBILITY GROUP BOX 1-INDUCED INFLAMMATION IN VIVO
van Zoelen, M. A. D., Yang, H., Florquin, S., Meijers, J. C. M., Akira, S., Arnold, B., Nawroth, P. P., Bierhaus, A., Tracey, K. J., & van der Poll, T. (2009) · Shock · doi:10.1097/shk.0b013e318186262d · Cited by 262
Receptor for Advanced-Glycation End Products: Key Modulator of Myocardial Ischemic Injury
Bucciarelli, L. G., Kaneko, M., Ananthakrishnan, R., Harja, E., Lee, L. K., Hwang, Y. C., Lerner, S., Bakr, S., Li, Q., Lu, Y., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.575993 · Cited by 256
Self-citation
RAGE Control of Diabetic Nephropathy in a Mouse Model
Myint, K.-M., Yamamoto, Y., Doi, T., Kato, I., Harashima, A., Yonekura, H., Watanabe, T., Shinohara, H., Takeuchi, M., Tsuneyama, K., et al. (2006) · Diabetes · doi:10.2337/db06-0221 · Cited by 250
Soluble Receptor for Advanced Glycation End Products: From Disease Marker to Potential Therapeutic Target
Geroldi, D., Falcone, C., & Emanuele, E. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777585013 · Cited by 249
Nonhistone Proteins HMG 1 and HMG 2 Change the DNA Helical Structure
Javaherian, K., Liu, L. F., & Wang, J. C. (1978) · Science · doi:10.1126/science.628842 · Cited by 248
RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes
Wendt, T., Harja, E., Bucciarelli, L. G., Qu, W., Lu, Y., Rong, L., Jenkins, D. G., Stein, G., Schmidt, A. M., & Yan, S. F. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.013 · Cited by 229
Self-citation
Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation.
Parkkinen, J., Raulo, E., Merenmies, J. M., Nolo, R. M., Kajander, E. O., Baumann, M., & Rauvala, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36575-5 · Cited by 216
Advanced glycation end-product cross-link breakersA novel approach to cardiovascular pathologies related to the aging process
Bakris, G. L., BANK, A., KASS, D., Neutel, J. M., Preston, R. A., & Oparil, S. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.08.022 · Cited by 210
Activation of Poly(ADP)-ribose Polymerase (PARP-1) Induces Release of the Pro-inflammatory Mediator HMGB1 from the Nucleus
Ditsworth, D., Zong, W., & Thompson, C. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701465200 · Cited by 208
The receptor for advanced glycation end‐products (RAGE) directly binds to ERK by a D‐domain‐like docking site
Ishihara, K., Tsutsumi, K., Kawane, S., Nakajima, M., & Kasaoka, T. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00846-9 · Cited by 201
Advanced Oxidation Protein Products Activate Vascular Endothelial Cells via a RAGE-Mediated Signaling Pathway
Guo, Z. J., Niu, H. X., Hou, F. F., Zhang, L., Fu, N., Nagai, R., Lu, X., Chen, B. H., Shan, Y., Tian, J. W., et al. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1999 · Cited by 193
Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications
Santilli, F., Vazzana, N., Bucciarelli, L. G., & Davı̀, G. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787581888 · Cited by 185
RAGE: a novel biological and genetic marker for vascular disease
Kalea, A. Z., Schmidt, A. M., & Hudson, B. I. (2009) · Clinical Science · doi:10.1042/cs20080494 · Cited by 184
Self-citation
Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling
Kohno, T., Anzai, T., Naito, K., Miyasho, T., Okamoto, M., Yokota, H., Yamada, S., Maekawa, Y., Takahashi, T., Yoshikawa, T., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn291 · Cited by 175
Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection
Lutterloh, E. C., Opal, S. M., Pittman, D. D., Keith, J. C., Tan, X., Clancy, B. M., Palmer, H. S., Milarski, K. L., Sun, Y., Palardy, J. E., et al. (2007) · Critical Care · doi:10.1186/cc6184 · Cited by 169
Soluble Receptor for Advanced Glycation End Products in Patients With Decreased Renal Function
Kalousová, M., Hodková, M., Kazderová, M., Fialová, J., Tesař, V., Sulková, S., & Zima, T. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.12.028 · Cited by 153
RAGE Ligation Affects T Cell Activation and Controls T Cell Differentiation
Chen, Y., Akirav, E. M., Chen, W., Henegariu, O., Moser, B., Desai, D. D., Shen, J. M., Webster, J. C., Andrews, R. C., Mjalli, A. M. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4272 · Cited by 148
Self-citation
Roles of the Receptor for Advanced Glycation Endproducts in Diabetes-Induced Vascular Injury
Yonekura, H., Yamamoto, Y., Sakurai, S., Watanabe, T., & Yamamoto, H. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cpj04005x · Cited by 148
The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940900101x · Cited by 145
Self-citation
High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice
Kitahara, T., Takeishi, Y., Harada, M., Niizeki, T., Suzuki, S., Sasaki, T., Ishino, M., Bilim, O., Nakajima, O., & Kubota, I. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn163 · Cited by 144
RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model
Aleshin, A., Ananthakrishnan, R., Li, Q., Rosario, R., Lu, Y., Qu, W., Song, F., Bakr, S., Szabolcs, M., D'Agati, V., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01210.2007 · Cited by 143
Self-citation
The Functional −374 T/A RAGE Gene Polymorphism Is Associated With Proteinuria and Cardiovascular Disease in Type 1 Diabetic Patients
Pettersson-Fernholm, K., Forsblom, C. M., Hudson, B. I., Perola, M., Grant, P. J., Groop, P., & for the FinnDiane Study Group (2003) · Diabetes · doi:10.2337/diabetes.52.3.891 · Cited by 136
The Relationship between Apoptosis and High-Mobility Group Protein 1 Release from Murine Macrophages Stimulated with Lipopolysaccharide or Polyinosinic-Polycytidylic Acid
Jiang, W., Bell, C. W., & Pisetsky, D. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6495 · Cited by 134
Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study
Dale, A. C., VATTEN, L. J., Nilsen, T. I. L., Midthjell, K., & Wiseth, R. (2008) · BMJ · doi:10.1136/bmj.39582.447998.be · Cited by 115
RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium
Bucciarelli, L. G., Ananthakrishnan, R., Hwang, Y. C., Kaneko, M., Song, F., Sell, D. R., Strauch, C., Monnier, V. M., Yan, S. F., Schmidt, A. M., et al. (2008) · Diabetes · doi:10.2337/db07-0326 · Cited by 113
Self-citation
Formins in cell signaling
Young, K. G., & Copeland, J. W. R. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.09.017 · Cited by 113
Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products
Liang, C., Ren, Y., Tan, H., He, Z., Jiang, Q., Wu, J., Zhen, Y., Fan, M., & Wu, Z. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00450.x · Cited by 111
Oxygen Deprivation Triggers Upregulation of Early Growth Response-1 by the Receptor for Advanced Glycation End Products
Chang, J. S., Wendt, T., Qu, W., Kong, L., Zou, Y. S., Schmidt, A. M., & Yan, S. (2008) · Circulation Research · doi:10.1161/circresaha.107.165308 · Cited by 110
Self-citation
RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice
Li, S., Ishida, T., Yasuda, T., Kojima, Y., Honjo, T., Yamamoto, Y., Yamamoto, H., Ishibashi, S., Hirata, K., & Hayashi, Y. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp036 · Cited by 109
Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains
Kuhla, B., Boeck, K., Schmidt, A., Ogunlade, V., Arendt, T., Münch, G., & Lüth, H.-J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.11.007 · Cited by 108
Self-citation
RAGE Ligand Upregulation of VEGF Secretion in ARPE-19 Cells
Ma, W., Lee, S. E., Guo, J., Qu, W., Hudson, B. I., Schmidt, A. M., & Barile, G. R. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0738 · Cited by 107
Self-citation
The Receptor for Advanced Glycation End Products Impairs Host Defense in Pneumococcal Pneumonia
van Zoelen, M. A. D., Schouten, M., de Vos, A. F., Florquin, S., Meijers, J. C. M., Nawroth, P. P., Bierhaus, A., & van der Poll, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801199 · Cited by 106
Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2
Chen, Q., Dong, L., Wang, L., Kang, L., & Xu, B. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.040 · Cited by 103
Receptor for Advanced Glycation End Products Expression on T Cells Contributes to Antigen-Specific Cellular Expansion In Vivo
Moser, B., Desai, D. D., Downie, M. P., Chen, Y., Yan, S. F., Herold, K. C., Schmidt, A. M., & Clynes, R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8051 · Cited by 100
Self-citation
Blockade of RAGE Suppresses Alloimmune Reactions In Vitro and Delays Allograft Rejection in Murine Heart Transplantation
Moser, B., Szabolcs, M., Ankersmit, H. J., Lu, Y. F., Qu, W., Weinberg, A. D., Herold, K., & Schmidt, A. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01617.x · Cited by 91
Self-citation
Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia
van Zoelen, M. A. D., van der Sluijs, K. F., Achouiti, A., Florquin, S., Pater, J. M., Yang, H., Nawroth, P. P., Tracey, K. J., Bierhaus, A., & van der Poll, T. (2009) · Virology · doi:10.1016/j.virol.2009.05.032 · Cited by 90
Modulated Inflammation by Injection of High-Mobility Group Box 1 Recovers Post-Infarction Chronically Failing Heart
Takahashi, K., Fukushima, S., Yamahara, K., Yashiro, K., Shintani, Y., Coppen, S. R., Salem, H. K., Brouilette, S., Yacoub, M. H., & Suzuki, K. (2008) · Circulation · doi:10.1161/circulationaha.107.757443 · Cited by 89
The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
Schmidt, A. M., Sahagan, B. G., Nelson, R. B., Selmer, J., Rothlein, R., & Bell, J. M. (2009) · PubMed · Cited by 86
Self-citation
S100B Expression Modulates Left Ventricular Remodeling After Myocardial Infarction in Mice
Tsoporis, J. N., Marks, A., Haddad, A., Dawood, F., Liu, P. P., & Parker, T. G. (2005) · Circulation · doi:10.1161/01.cir.0000154554.65287.f5 · Cited by 82
Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury
Zeng, S., Dun, H., Ippagunta, N., Rosario, R., Zhang, Q. Y., Lefkowitch, J. H., Yan, S. F., Schmidt, A. M., & Emond, J. C. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.11.022 · Cited by 77
Self-citation
Proteomic analysis defines altered cellular redox pathways and advanced glycation end-product metabolism in glomeruli ofdb/dbdiabetic mice
Barati, M. T., Merchant, M. L., Kain, A. B., Jevans, A. W., McLeish, K. R., & Klein, J. B. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00411.2006 · Cited by 74
Production of Nε-(Carboxymethyl)Lysine Is Impaired in Mice Deficient in NADPH Oxidase
Anderson, M. M., & Heinecke, J. W. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2137 · Cited by 73
S100B is expressed in, and released from, OLN-93 oligodendrocytes: Influence of serum and glucose deprivation
Steiner, J. H., Bernstein, H., Bogerts, B., Gos, T., Richter‐Landsberg, C., Wunderlich, M., & Keilhoff, G. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.03.060 · Cited by 69
beta2-Microglobulin modified with advanced glycation end products delays monocyte apoptosis
Hou, F. F., Miyata, T., Boyce, J. A., Yuan, Q., Chertow, G. M., Kay, J., Schmidt, A. M., & Owen, W. F. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059003990.x · Cited by 67
Self-citation
HIGH LEVELS OF SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS MAY BE A MARKER OF EXTREME LONGEVITY IN HUMANS
Geroldi, D., Falcone, C., Minoretti, P., Emanuele, E., Arra, M., & D’Angelo, A. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00776.x · Cited by 66
Receptor for Advanced Glycation End Products Facilitates Host Defense duringEscherichia coli–Induced Abdominal Sepsis in Mice
van Zoelen, M. A. D., Schmidt, A., Florquin, S., Meijers, J. C. M., de Beer, R., de Vos, A. F., Nawroth, P. P., Bierhaus, A., & van der Poll, T. (2009) · The Journal of Infectious Diseases · doi:10.1086/604730 · Cited by 65
Self-citation
Regulation of HMGB1 release by autophagy
Thorburn, J., Frankel, A. E., & Thorburn, A. M. (2009) · Autophagy · doi:10.4161/auto.5.2.7552 · Cited by 56
Soluble RAGE-Modulating Drugs: State-of-the-Art and Future Perspectives for Targeting Vascular Inflammation
Lanati, N., Emanuele, E., Brondino, N., & Geroldi, D. (2010) · Current Vascular Pharmacology · doi:10.2174/157016110790226642 · Cited by 54
Blockade of receptor for advanced glycation end product attenuates pulmonary reperfusion injury in mice
Sternberg, D. I., Gowda, R., Mehra, D., Qu, W., Weinberg, A. D., Twaddell, W. S., Sarkar, J., Wallace, A., Hudson, B. I., D’Ovidio, F., et al. (2008) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2008.05.032 · Cited by 52
Self-citation
Neuronal RAGE expression modulates severity of injury following transient focal cerebral ischemia
Hassid, B. G., Nair, M. N., Ducruet, A. F., Otten, M. L., Komotar, R. J., Pinsky, D. J., Schmidt, A. M., Yan, S. F., & Connolly, E. S. (2008) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2007.12.011 · Cited by 48
Self-citation
Dietary Bread Crust Advanced Glycation End Products Bind to the Receptor for AGEs in HEK‐293 Kidney Cells but Are Rapidly Excreted after Oral Administration to Healthy and Subtotally Nephrectomized Rats
Somoza, V., Lindenmeier, M., Hofmann, T. F., Frank, O., Erbersdobler, H. F., Baynes, J., Thorpe, S. R., Heidland, A., Zill, H., Bek, S., et al. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.056 · Cited by 44
The −374T/A RAGE Polymorphism Protects Against Future Cardiac Events in Nondiabetic Patients with Coronary Artery Disease
Falcone, C., Geroldi, D., Buzzi, M. P., Emanuele, E., Yilmaz, Y. N., Fontana, J. M., Vignali, L., Boiocchi, C., Sbarsi, I., & Cuccia, M. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.11.003 · Cited by 42
The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study
Hofmann, M. A., Yang, Q., Harja, E., Kedia, P. S., Gregersen, P. K., Cupples, L. A., Schmidt, A. M., & Hudson, B. I. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.02.006 · Cited by 42
Self-citation
C-reactive Protein Upregulates Receptor for Advanced Glycation End Products Expression and Alters Antioxidant Defenses in Rat Endothelial Progenitor Cells
Chen, J., Huang, L. J., Song, M., Yu, S., Gao, P., & Jing, J. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31819b5438 · Cited by 42
Diabetes Mellitus, Hypothalamic Hypoestrogenemia, and Coronary Artery Disease in Premenopausal Women (from the National Heart, Lung, and Blood Institute Sponsored WISE Study)
Ahmed, B., Merz, C. N. B., Johnson, B. D., Bittner, V., Berga, S. L., Braunstein, G. D., Hodgson, T. K., Smith, K., Shaw, L. J., Kelsey, S. F., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.03.029 · Cited by 29
Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies
Engelen, L., Ferreira, I., Brouwers, O., Henry, R. M. A., Dekker, J. M., Nijpels, G., Heine, R. J., van Greevenbroek, M. M. J., Kallen, C., Blaak, E. E., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832af6ba · Cited by 28
Glyoxalase I activity and immunoreactivity in the aging human lens
Mailankot, M., Padmanabha, S., Pasupuleti, N., Major, D. L., Howell, S. J., & Nagaraj, R. H. (2009) · Biogerontology · doi:10.1007/s10522-009-9218-2 · Cited by 27
Common polymorphisms in the glyoxalase-1 gene and their association with pro-thrombotic factors
Gale, C. P., Futers, T. S., & Summers, L. K. M. (2004) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2004.004 · Cited by 25
HMGB1 release in co‐cultures of porcine endothelial and human T cells
Kawahara, K., Setoyama, K., Kikuchi, K., Biswas, K. K., KAMIMURA, R., Iwata, M., Ito, T., Morimoto, Y., Hashiguchi, T., Takao, S., et al. (2007) · Xenotransplantation · doi:10.1111/j.1399-3089.2007.00434.x · Cited by 24
Glycation and oxidation of human low density lipoproteins reduces heparin binding and modifies charge
Creriche, A. G., & Stahl, A. J. C. (1993) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519309088399 · Cited by 23
Early increases in serum S100B are associated with cerebral hemorrhage in a rat model of focal cerebral ischemia
Tanaka, Y., Marumo, T., Omura, T., & Yoshida, S. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.076 · Cited by 20
What does high NT-proBNP mean in septic shock patients? A part of the puzzle
Roch, A. (2007) · Critical Care · doi:10.1186/cc5728 · Cited by 15
Polyol pathway inhibition improves age‐related vascular dysfunction in rats
Hallam, K. M., Gomez, T., Li, Q., Ananthakrishnan, R., Yan, S. F., Schmidt, A. M., & Ramasamy, R. (2006) · The FASEB Journal · doi:10.1096/fasebj.20.4.a721-c · Cited by 6
Self-citation
Pharmacological blockade of the receptor for advanced glycation endproducts (RAGE) improves age‐related endothelial dysfunction in rats
Hallam, K. M., Gomez, T., Li, Q., Ananthakrishnan, R., Yan, S. F., Qu, W., Schmidt, A. M., & Ramasamy, R. (2006) · The FASEB Journal · doi:10.1096/fasebj.20.5.a1167-c · Cited by 2
Self-citation

Sorted by citations

Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Association between insulin resistance and the development of cardiovascular disease
Ormazábal, V., Nair, S., Elfeky, O. W. M., Aguayo, C. R., Salomón, C., & Zuñiga, F. A. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0762-4 · Cited by 2,432
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
Paneni, F., Beckman, J. A., Creager, M. A., & Cosentino, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht149 · Cited by 1,455
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Bornfeldt, K., & Tabas, I. A. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.07.015 · Cited by 1,020

See all 381

Authors: Yan, S. F., Ramasamy, R., & Schmidt, A. M.
Affiliations: Columbia University (US)
ORCID: Yan, Shi Fang
Ramasamy, Ravichandran
Schmidt, Ann Marie
Venue: Circulation Research
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2010-03-19
Volume: 106
Issue: 5
Pages: 842-853
ISSN: 0009-7330 (ISSN-L)
1524-4571
DOI: 10.1161/circresaha.109.212217
PMC: PMC2862596
OpenAlex: W2118046722
Cited by: 381
References: 100
Citations by year: 2026: 11 · 2025: 18 · 2024: 10 · 2023: 17 · 2022: 22 · 2021: 22 · 2020: 21 · 2019: 20 · 2018: 23 · 2017: 25 · 2016: 21 · 2015: 26 · 2014: 34 · 2013: 34 · 2012: 34
FWCI: 3.64
Type: journal article
Language: en
Update notices: correction (2010-04-30)
Open access: bronze
doi.org
Locations: Circulation Research (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Aging (P01AG026467)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords: receptor for advanced glycation end products, RAGE, advanced glycation end products, advanced oxidation protein products, S100/calgranulins, high mobility group box 1, amyloid-beta, β-sheet fibrils, diabetes mellitus, hyperglycemia, oxidative stress, inflammation, thrombosis, atherosclerosis, diabetic cardiomyopathy
MeSH terms: Receptor for Advanced Glycation End Products, Animals, Blood Vessels, Cardiovascular Diseases, Diabetes Mellitus, Humans, Immunity, Innate, Ligands, Polymorphism, Genetic, Protein Processing, Post-Translational, Receptors, Immunologic, Signal Transduction, Diabetes Complications, Adaptive Immunity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The RAGE Axis: A Fundamental Mechanism Signaling Danger to the Vulnerable Vasculature

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks